IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ponoi II Management, LLC

Q1 2022 Holdings

Filed 2022-05-16 | 4 holdings | $45.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$19.8K1,298,90844.0%
Revolution Medicines Inc(RVMD)COM76155X100$17.5K685,01138.8%
Nurix Therapeutics Inc(NRIX)COM67080M103$4.6K327,12310.2%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$3.2K145,4017.1%